On February 25, 2011, the State Food and Drug Administration (SFDA) held a videoconference on carrying out Good Manufacturing Practice for Pharmaceutical Products (2010 revised edition) (hereinafter referred to as the new version of GMP). The conference introduced the significances and characteristics of the new version of GMP and made detailed arrangements on the next-stage work. SFDA Deputy Commissioner Wu Zhen attended the conference and gave a speech.

 

According to the conference: as of March 1, 2011, all the newly built drug manufacturers and the newly built (reconstructed or extended) workshops of drug manufacturers should comply with the requirements of the new version of GMP; the production of blood products, vaccines, injections and other sterile pharmaceutical products in existing drug manufacturers should meet the requirements of the new version of GMP before December 31, 2013; the production of other category of pharmaceutical products should meet the requirements of the new version of GMP before December 31, 2015; drug manufacturers (workshops) fail to meet the requirements of the new version of GMP are not allowed to continue their drug production after the above deadlines.